DOI 10.1016/j.fertnstert.2004.07.952 10.1016/j.fertnstert.2004.07.952
Cite this article
Mitwally, M. F., & Casper, R. F. (2005). Single-dose administration of an aromatase inhibitor for ovarian stimulation. *Fertility and Sterility*, *83*(1), 229-231. https://doi.org/10.1016/j.fertnstert.2004.07.952
Mitwally MF, Casper RF. Single-dose administration of an aromatase inhibitor for ovarian stimulation. Fertility and Sterility. 2005;83(1):229-231. doi:10.1016/j.fertnstert.2004.07.952
Mitwally, M. F., and R. F. Casper. "Single-dose administration of an aromatase inhibitor for ovarian stimulation." *Fertility and Sterility*, vol. 83, no. 1, 2005, pp. 229-231.
The third-generation aromatase inhibitors were initially introduced to treat postmenopausal breast cancer. We now realize that many other potential indications for aromatase inhibitors exist, especial...
OBJECTIVE: To use aromatase inhibition for induction of ovulation in women in whom clomiphene citrate (CC) treatment was unsuccessful.
DESIGN: Prospective trial in infertility patients treated with C...
Mitwally MF et al., 2004Seminars in Reproductive Medicine
The new third generation aromatase inhibitors are extremely potent and specific oral inhibitors of estrogen production. We reported the success of using aromatase inhibitors for induction of ovulation...
Objective: To examine birth outcomes between children conceived with in vitro fertilization (IVF) or intrauterine insemination (IUI) and sibling births from unassisted conceptions.
Design: Retrospect...
Infertility > Assisted Reproductive Technology > IVF OutcomesPregnancy > Neonatal Outcomes > Birth Weight and Gestational AgeContraception/Comparison > ART vs Natural Conception > Sibling Studies